The 5-Second Trick For lenmeldy
The FDA assessed the security and performance of atidarsagene autotemcel determined by knowledge from 37 young children who obtained atidarsagene autotemcel in two one-arm, open-label clinical trials As well as in an expanded accessibility method.[7] Small children who gained remedy with atidarsagene autotemcel were compared to untreated youngsters